“The 40-Gene Expression Profile Test Identifies Patients With National Comprehensive Cancer Network High-Risk Cutaneous Squamous Cell Carcinoma at High Risk of Poor Outcomes to Inform Management Decisions”. SKIN The Journal of Cutaneous Medicine, vol. 9, no. 4, July 2025, pp. 2426-43, https://doi.org/10.25251/mvr2rn83.